web analytics
Italian Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 1 - 20 out of 154 displayed.
1  2  3  4  5  6  7  8 »

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

Read more ››
By: GlobeNewswire - 07 Oct 2024

PROMISING CELL THERAPY OFFERS HOPE FOR RELAPSED OR REFRACTORY T-CELL LEUKAEMIA

Read more ››
By: PR Newswire Association LLC. - 05 Oct 2024

Nouscom to Present Updated Positive Data on NOUS-209’s Potential to ‘Intercept’ Cancer in Lynch Syndrome Carriers at SITC 2024

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Nouscom SRL

RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISE

Read more ››
By: GlobeNewswire - 04 Oct 2024

レコルダティ、エジャイモ®のグローバル権利取得に合意し、希少疾患事業を強化

Read more ››
By: GlobeNewswire - 04 Oct 2024

Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda

Read more ››
By: PR Newswire Association LLC. - 04 Oct 2024

Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Genenta Science s.r.l.

10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting

Read more ››
By: PR Newswire Association LLC. - 01 Oct 2024

Bristol Myers Squibb Marks 10 Years of Global Patient Week with Community Initiatives in the Region

Read more ››
By: PR Newswire Association LLC. - 30 Sep 2024

SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board

Read more ››
By: GlobeNewswire - 30 Sep 2024

European Commission approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)

Read more ››
By: GlobeNewswire - 30 Sep 2024

CARVYKTI® ▼ (ciltacabtagene autoleucel; cilta-cel) is the first cell therapy to significantly extend overall survival versus standard therapies for patients with multiple myeloma as early as second line

Read more ››
By: GlobeNewswire - 27 Sep 2024

DARZALEX® (daratumumab) subcutaneous (SC) formulation-based quadruplet regimen significantly improves minimal residual disease negativity for newly diagnosed multiple myeloma patients for whom transplant is not planned

Read more ››
By: GlobeNewswire - 27 Sep 2024

Novel combination of TALVEY®▼ (talquetamab) and TECVAYLI®▼ (teclistamab) suggest high response rates and durable responses in triple-class refractory patients with relapsed or refractory multiple myeloma, including those with extramedullary disease

Read more ››
By: GlobeNewswire - 27 Sep 2024

TALVEY®▼ (talquetamab) and DARZALEX® (daratumumab) subcutaneous (SC) formulation-based combination shows deep and durable responses in patients with relapsed or refractory multiple myeloma

Read more ››
By: GlobeNewswire - 27 Sep 2024

Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities

Read more ››
By: GlobeNewswire - 27 Sep 2024

Medit Expands Intraoral Scanner Presence in Slovenia and the Balkans

Read more ››
By: PR Newswire Association LLC. - 27 Sep 2024

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

Read more ››
By: GlobeNewswire - 26 Sep 2024

Boehringer Ingelheim expands cancer research at its Vienna site

Read more ››
By: GlobeNewswire - 25 Sep 2024

Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic

Read more ››
By: GlobeNewswire - 25 Sep 2024
Related companies:  GeneSpire Srl
1  2  3  4  5  6  7  8 »

Looking for companies outside of Italy?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • October 2024
    • Copenhagen: LSX Nordic Congress
    • Basel: BiotechX Europe 2024
    • Amsterdam: World Drug Safety Congress Europe
See Events »
Add an Event »

Latest company news

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates
07 Oct 2024 (GlobeNewswire)

PROMISING CELL THERAPY OFFERS HOPE FOR RELAPSED OR REFRACTORY T-CELL LEUKAEMIA
05 Oct 2024 (PR Newswire Association LLC.)

Nouscom to Present Updated Positive Data on NOUS-209’s Potential to ‘Intercept’ Cancer in Lynch Syndrome Carriers at SITC 2024
04 Oct 2024 (GlobeNewswire)

Biotechgate database

About Biotechgate
The Italian Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com